Related Experiment Video
Updated: Aug 15, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Prophylaxis of HIV infection
Ali S Omrani1, Andrew Freedman
1Infectious Diseases Unit, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK. ali.omrani@doctors.org.uk
British Medical Bulletin
|October 7, 2005
Summary
Post-exposure prophylaxis (PEP) can prevent HIV infection after exposure but has side effects. Primary prevention remains crucial for controlling the HIV epidemic.
Area of Science:
- Infectious Diseases
- Public Health
- Virology
Background:
- HIV infection rates continue to rise globally.
- Post-exposure prophylaxis (PEP) offers a potential intervention to prevent HIV transmission after exposure.
- Biological plausibility and limited studies support PEP's efficacy.
Purpose of the Study:
- To review the role and considerations for Post-exposure prophylaxis (PEP) in preventing HIV infection.
- To highlight the importance of weighing benefits against risks associated with antiretroviral prophylaxis.
- To emphasize that PEP is not a substitute for primary HIV prevention strategies.
Main Methods:
- Review of existing literature and guidelines on Post-exposure prophylaxis (PEP).
- Analysis of the biological basis for PEP effectiveness.
- Consideration of clinical scenarios for PEP application.
Main Results:
- Antiretroviral prophylaxis for PEP is associated with significant side effects.
- PEP should be considered for significant occupational and non-occupational HIV exposures.
- PEP is not appropriate for individuals with repeated high-risk behaviors unwilling to adopt risk reduction.
Conclusions:
- Primary prevention strategies are essential for HIV epidemic control and cannot be replaced by PEP.
- PEP is a valuable tool when used appropriately following HIV exposure.
- Guidelines for PEP are available internationally, underscoring its recognized role in HIV prevention.
Related Concept Videos
Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

